Schema.org Vocabulary › Class: DrugPregnancyCategory

DrugPregnancyCategory

https://schema.org/DrugPregnancyCategory

Categories that represent an assessment of the risk of fetal injury due to a drug or pharmaceutical used as directed by the mother during pregnancy.

Subclass of: MedicalEnumeration

Properties from DrugPregnancyCategory

No properties defined directly on this class.

Properties from Enumeration

PropertyDescriptionRange
supersededByRelates a term (i.e. a property, class or enumeration) to one that supersedes it.Enumeration, Property, Class

Properties from Thing

PropertyDescriptionRange
potentialActionIndicates a potential Action, which describes an idealized action in which this thing would play an 'object' role.Action
imageAn image of the item. This can be a [[URL]] or a fully described [[ImageObject]].URL, ImageObject
sameAsURL of a reference Web page that unambiguously indicates the item's identity. E.g. the URL of the item's Wikipedia page, Wikidata entry, or official website.URL
ownerA person or organization who owns this Thing.Organization, Person
descriptionA description of the item.TextObject, Text
subjectOfA CreativeWork or Event about this Thing.Event, CreativeWork
urlURL of the item.URL
additionalTypeAn additional type for the item, typically used for adding more specific types from external vocabularies in microdata syntax. This is a relationship between something and a class that the thing is in. Typically the value is a URI-identified RDF class, and in this case corresponds to the use of rdf:type in RDF. Text values can be used sparingly, for cases where useful information can be added without their being an appropriate schema to reference. In the case of text values, the class label should follow the schema.org style guide.Text, URL
disambiguatingDescriptionA sub property of description. A short description of the item used to disambiguate from other, similar items. Information from other properties (in particular, name) may be necessary for the description to be useful for disambiguation.Text
alternateNameAn alias for the item.Text
nameThe name of the item.Text
identifierThe identifier property represents any kind of identifier for any kind of [[Thing]], such as ISBNs, GTIN codes, UUIDs etc. Schema.org provides dedicated properties for representing many of these, either as textual strings or as URL (URI) links. See [background notes](/docs/datamodel.html#identifierBg) for more details. Text, URL, PropertyValue
mainEntityOfPageIndicates a page (or other CreativeWork) for which this thing is the main entity being described. See [background notes](/docs/datamodel.html#mainEntityBackground) for details.CreativeWork, URL

Enumeration Values

ValueDescription
https://schema.org/FDAcategoryA FDAcategoryAA designation by the US FDA signifying that adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
https://schema.org/FDAcategoryB FDAcategoryBA designation by the US FDA signifying that animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
https://schema.org/FDAcategoryC FDAcategoryCA designation by the US FDA signifying that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
https://schema.org/FDAcategoryD FDAcategoryDA designation by the US FDA signifying that there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
https://schema.org/FDAcategoryX FDAcategoryXA designation by the US FDA signifying that studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
https://schema.org/FDAnotEvaluated FDAnotEvaluatedA designation that the drug in question has not been assigned a pregnancy category designation by the US FDA.